A Randomized, Double-blind, Parallel Group, Active-controlled, 38-week Study to Evaluate the Efficacy of Valsartan Versus Amlodipine on the Arterial Properties of Postmenopausal Women With Mild to Moderate Hypertension.
Phase of Trial: Phase IV
Latest Information Update: 01 Nov 2012
At a glance
- Drugs Valsartan (Primary) ; Amlodipine; Hydrochlorothiazide
- Indications Hypertension
- Focus Pharmacodynamics
- 01 Nov 2012 Results published in the Journal of Clinical Hypertension.
- 02 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 May 2011 Actual end date (Oct 2007) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History